Bjarne Kuno Møller (Bjarne K Møller)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Topics

Acute Ischemic Stroke

Randomized Controlled Trial

Dendritic Cells

Top Venues

International journal of molecular sciences

International reviews of immunology

Clinical and experimental immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Anders Munk, Christina Søndergaard Duvald, Michael Pedersen, Stine Lohmann, Anna Krarup Keller, Bjarne Kuno Møller, Steffen Ringgaard, Niels Henrik Buus, Bente Jespersen, Marco Eijken
Dosing Limitation for Intra-Renal Arterial Infusion of Mesenchymal Stromal Cells. International journal of molecular sciences 23 (15) (2022)
Maya Graham Pedersen, Bjarne Kuno Møller, Rasmus O Bak
Recent Advances in the Development of Anti-FLT3 CAR T-Cell Therapies for Treatment of AML. Biomedicines 10 (10) (2022)
Marie Bodilsen Nielsen, Kristian Ravlo, Marco Eijken, Nicoline Valentina Krogstrup, Morten B Svendsen, Chadi Nimeh Abdel-Halim, Mikkel V Petersen, Henrik Birn, Mihai Oltean, Bente Jespersen, Bjarne Kuno Møller
Dynamics of circulating dendritic cells and cytokines after kidney transplantation-No effect of remote ischaemic conditioning. Clinical and experimental immunology 206 (2) (2021)
Jens Magnus Bernth Jensen, Sune Skeldal, Mikkel Steen Petersen, Bjarne Kuno Møller, Steen Hoffmann, Jens Christian Jensenius, Uffe B Skov Sørensen, Steffen Thiel
The human natural anti-αGal antibody targets common pathogens by broad-spectrum polyreactivity. Immunology 162 (4) (2021)
Thomas H Lange, Marco Eijken, Carla Baan, Mikkel Steen Petersen, Bo Martin Bibby, Bente Jespersen, Bjarne Kuno Møller
Early Immunological Effects of Ischemia-Reperfusion Injury: No Modulation by Ischemic Preconditioning in a Randomised Crossover Trial in Healthy Humans. International journal of molecular sciences 20 (12) (2019)
Pernille Koefoed-Nielsen, Bjarne Kuno Møller
Donor-specific anti-HLA antibodies by solid phase immunoassays: advantages and technical concerns. International reviews of immunology 38 (3) (2018)